Skip to content
Hybrid Assays for Protein Bioanalysis episode artwork

Jul 29, 2020 24 min

Hybrid Assays for Protein Bioanalysis

from Laboratory Considerations for Clinical Trials Hosted by Q Squared Solutions

In this episode, Drs. Steven Lowes and Barry Jones discuss hybrid assays, combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS). This is a growing area of opportunity for protein bioanalysis. Topics covered include: What is meant by hybrid assay Reasons to choose a hybrid assay Top down vs bottom up Specific challenges Assay design considerations Future potential for this type of bioanalysis ...I think that fundamental point about more sensitivity, and associated with that is more selectivity, is going to be part of the future adoption of these hybrid assays. We have needs already, we can see needs for looking at quantifying proteins in very small samples, say tissue biopsies. - Steven Lowes Learn more at Q2labsolutions.com. Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision (Article in Clinical Chemistry)

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Hybrid Assays for Protein Bioanalysis

0:00 24:21

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Laboratory Considerations for Clinical Trials?

This episode is 24 minutes long.

When was this Laboratory Considerations for Clinical Trials episode published?

This episode was published on July 29, 2020.

Can I download this Laboratory Considerations for Clinical Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.